RICHMOND, Va., Oct. 15, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) this week published compelling results from a multicenter, open-label clinical trial published in JAMA Network Open. Two ...

Patients not already receiving buprenorphine can receive the first injection of Sublocade following a single dose of transmucosal buprenorphine and a 1 hour observation period to confirm tolerability.

If each episode of a podcast is an organ, an essential piece of a larger body, then this is an appendix to that body: a non-essential but still uniquely formed bonus episode. In it you’ll hear a ...

Indivior recently released results from a multicenter, open-label clinical trial showing that rapid induction with SUBLOCADE, using a single 4 mg oral buprenorphine dose followed by a same-day ...

RICHMOND - Indivior PLC (NASDAQ:INDV), a pharmaceutical company with a market capitalization of $3.1 billion and an impressive 207% return over the past year, announced Wednesday that a new clinical ...

Writing for The Conversation, David Acunzo, an assistant professor in the Division of Perceptual Studies at the University of Virginia School of Medicine, examines when and why hypnosis may be used ...